Screening for chlamydia trachomatis and neisseria gonorrhoeae during pregnancy: a health technology assessment

Kanga I, Williams D, Hatchette T, MacKinnon SB, Jung H, Black C, Tsoi B, Brundisini F, DeJean D, Weeks L, Ford C, Kaunelis D
Record ID 32018002216
English
Authors' objectives: The purpose of this HTA is to address the policy question through an assessment of the clinical effectiveness and safety, and cost-effectiveness, and patients’, partners’, and health care providers’ perspectives and experiences regarding the screening of pregnant persons for CT and GC. An analytic framework for the HTA can be found in Appendix 1.
Details
Project Status: Completed
Year Published: 2018
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: Canada
Pubmed ID: 31145563
MeSH Terms
  • Sexually Transmitted Diseases
  • Chlamydia Infections
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Mass Screening
  • Pregnancy
  • Pregnancy Complications, Infectious
  • Gonorrhea
Keywords
  • Sexually transmitted diseases
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Pregnancy
Contact
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name: requests@cadth.ca
Contact Email: requests@cadth.ca
Copyright: <p>Canadian Agency for Drugs and Technologies in Health (CADTH)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.